Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment.
about
Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review.Persistent Chlamydiae and chronic arthritisLead Discovery Strategies for Identification of Chlamydia pneumoniae InhibitorsGenetic diversity of the obligate intracellular bacterium Chlamydophila pneumoniae by genome-wide analysis of single nucleotide polymorphisms: evidence for highly clonal population structure.Chlamydia pneumoniae hides inside apoptotic neutrophils to silently infect and propagate in macrophages.New perspectives of infections in cardiovascular diseaseClarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart diseaseChlamydophila pneumoniae Infection and Its Role in Neurological Disorders.Chlamydia trachomatis persistence in vitro: an overviewChlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studiesChlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo.Degradation of Chlamydia pneumoniae by peripheral blood monocytic cells.Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors required for [correction of factors is required for] major histocompatibility complex antigen expression.Inhibitory activity of the isoflavone biochanin A on intracellular bacteria of genus Chlamydia and initial development of a buccal formulation.Chlamydia pneumoniae resists antibiotics in lymphocytes.The role of infection in the pathogenesis of cardiovascular disease.Impact of monocytic cells on recovery of uncultivable bacteria from atherosclerotic lesions.Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment.Persistent Chlamydia pneumoniae infection of cardiomyocytes is correlated with fatal myocardial infarctionAntibiotic trials for coronary heart disease.NLRP3 inflammasome is a target for development of broad-spectrum anti-infective drugsSurvival of Chlamydia muridarum within dendritic cellsImpact of micro-environmental changes on respiratory tract infections with intracellular bacteria.The effect of infections and vaccinations on stroke risk.Chlamydia pneumoniae growth inhibition in cells by the steroid receptor antagonist RU486 (mifepristone).Chlamydia pneumoniae infection acts as an endothelial stressor with the potential to initiate the earliest heat shock protein 60-dependent inflammatory stage of atherosclerosisRifalazil and other benzoxazinorifamycins in the treatment of chlamydia-based persistent infections.Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J miceLipopolysaccharide, CD14 and Toll-like receptors: an emerging link between innate immunity and atherosclerotic disease.Glucocorticoids increase in vitro and in vivo activities of antibiotics against Chlamydophila pneumoniae.Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?Possibilities for therapeutic interventions in disrupting Chlamydophila pneumoniae involvement in atherosclerosis.CCL19-CCR7-dependent reverse transendothelial migration of myeloid cells clears Chlamydia muridarum from the arterial intima.Interaction of Chlamydiae with human macrophages.Recent advances in technologies for developing drugs against Chlamydia pneumoniae.Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials.Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: a brief overview.Effects of coadministration of natural polyphenols with doxycycline or calcium modulators on acute Chlamydia pneumoniae infection in vitro.Analysis of Chlamydia pneumoniae infection in mononuclear cells by reverse transcription-PCR targeted to chlamydial gene transcripts.
P2860
Q24791856-4F20BC61-3D54-4BAC-AC86-9E3675B7E266Q24792605-23AD5CAD-3FD3-48F2-A4A5-C22FAD370317Q28069433-F2BB8909-B014-4E00-9BA6-E977163B5650Q33301584-193A7106-14A2-4292-A8FD-057B370DC77FQ33472674-734A596B-7089-43E3-9AFB-D96402BD84B9Q33587960-E6B650B3-3E89-497B-BF88-62C2AD47EF9BQ33646625-CEF1EEFE-AED6-4B71-9A97-371538CF25FCQ33674644-E431607D-FD75-4CD4-9FB8-B75D116494E4Q33885404-BD21D182-D34E-4682-B60D-8C28A4759495Q33905858-4E3E8752-0578-43E6-89BB-ADA9BDCF99B1Q33927267-DD507DCD-0155-45DA-8E9A-A8EA7F294F5DQ33946655-884488D8-DE1D-419B-A176-91461DF85F0CQ33983273-42A1C9AC-0B6D-4188-89E2-48EAB7682E1FQ34116447-6EC58705-D92F-4AC5-90BB-02FE7AF1AC0DQ34712836-E3944B63-C891-48FD-815E-7F34990DA24EQ35014062-63FCC687-78E5-45AF-B07A-3AEE9F19CABBQ35080677-3D724EF2-5145-4676-8502-6F8DAFD9BBE7Q35097901-7BF2E432-FC7C-43FB-A600-1497C21BD868Q35535328-4C7BF062-7A24-4EF2-83A5-121D647B357AQ35570353-AD49ED38-F26E-4775-85F0-9CCEB97FDCEDQ35733945-23A33CCD-C9DB-4C9B-8980-1982DCC40480Q35867294-2F87FF6B-3020-4AAB-A5A2-BD53EF0F285FQ35949817-37760EC9-2866-47CD-B7DC-AEEADE5CBE56Q36100313-0DFB1F42-A67F-4607-873F-638FFCE5B526Q36390814-00353FC6-2240-4A2B-95F0-5A682B549C30Q36703071-2F4B276B-6630-45A2-B2B6-4670E5D2B97CQ36780378-27D55688-8AD5-40A9-AFD1-01D210258F78Q36958999-F2F531C2-E794-4CA0-8EE4-EC209E04C5FCQ37568474-2A8D9B2B-0C99-4C76-AF0A-E47924B213C5Q37608487-C7E9A29D-CEDC-470F-987F-362B4117DCDAQ37624924-63CFE907-42B0-4DDA-85B7-0242B02F1752Q37743247-F09864C4-2976-4DE1-A755-0D3A29AC5B4BQ37775097-4CC2A5C3-0552-4BE6-A34B-349E574CC7F1Q37835548-F8C93D8D-2DF5-4042-B5E2-A588EC552FB6Q37838397-E19019E5-569C-442C-A2E7-B6395DEEE4BAQ37844406-0F0F1889-07AD-4AE8-829F-EC117E8B34E2Q37844575-702BBE81-9632-484A-AB29-EE1E9D8F82C7Q37846181-3E24D77F-9EEC-400E-B8E4-BCDF50A826A7Q37850156-92F541A7-D47F-4EDC-99BB-5BC6A9636FEBQ37851467-2F2AB5AA-7C5D-40CA-95DA-AEE116B09923
P2860
Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Chlamydia pneumoniae infection ...... ctory to antibiotic treatment.
@ast
Chlamydia pneumoniae infection ...... ctory to antibiotic treatment.
@en
type
label
Chlamydia pneumoniae infection ...... ctory to antibiotic treatment.
@ast
Chlamydia pneumoniae infection ...... ctory to antibiotic treatment.
@en
prefLabel
Chlamydia pneumoniae infection ...... ctory to antibiotic treatment.
@ast
Chlamydia pneumoniae infection ...... ctory to antibiotic treatment.
@en
P2093
P356
P1433
P1476
Chlamydia pneumoniae infection ...... ctory to antibiotic treatment.
@en
P2093
Füllgraf H
Gieffers J
P304
P356
10.1161/01.CIR.103.3.351
P407
P577
2001-01-01T00:00:00Z